Physician profile
Muna Hale
NPI 1801257134
$4,826.65
in general payments reported to CMS, 2019-2025
34 companies · $777 in 2025
The $777 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $119 · 2021: $680 · 2022: $774 · 2023: $1,022 · 2024: $1,082 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,880.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $514.02 | 2023-2025 | |
| Travere Therapeutics, INC. | $502.67 | 2022-2025 | |
| Amgen INC. | $404.42 | 2019-2025 | Krystexxa, Tavneos |
| Astrazeneca Pharmaceuticals LP | $311.73 | 2021-2024 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $252.33 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $237.22 | 2021-2025 | Jynarque |
| Vifor Pharma, INC. | $210.38 | 2021-2024 | Veltassa |
| Aurinia Pharma U.S., INC. | $208.04 | 2021-2024 | Lupkynis |
| Calliditas Therapeutics US INC. | $191.62 | 2022-2025 | Tarpeyo |
| Fresenius USA Marketing, INC. | $163.05 | 2021-2025 | Velphoro, Velphoro, Korsuva |
| Opko Pharmaceuticals, LLC | $162.09 | 2021-2023 | Rayaldee |
| Nxstage Medical, INC. | $131.35 | 2022-2023 | Nxstage System One |
| Alexion Pharmaceuticals, INC. | $124.88 | 2022-2024 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.87 | 2024-2025 | Jardiance |
| Abbott Laboratories | $122.94 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $118.91 | 2021 | |
| Pfizer INC. | $118.87 | 2020 | |
| Viiv Healthcare Company | $114.26 | 2019 | |
| Horizon Therapeutics Plc | $113.53 | 2022-2023 | Krystexxa |
| Genzyme Corporation | $94.56 | 2019 | |
| Daiichi Sankyo INC. | $86.89 | 2021-2023 | Injectafer |
| Mallinckrodt Hospital Products INC. | $83.88 | 2021-2025 | Terlivaz |
| Lilly USA, LLC | $76.59 | 2019-2024 | Jardiance |
| Recordati_rare_diseases_inc. | $62.54 | 2022-2023 | Cystadrops |
| Ani Pharmaceuticals, INC. | $53.27 | 2023 | Purified Cortrophin Gel |
| Ardelyx, INC. | $52.42 | 2024-2025 | Ibsrela |
| Novo Nordisk INC | $42.57 | 2025 | Ozempic |
| Glaxosmithkline, LLC. | $28.41 | 2021 | |
| Scpharmaceuticals INC. | $27.26 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.56 | 2021 | |
| Eusa Pharma (US) LLC | $18.37 | 2022 | |
| Cormedix INC. | $16.82 | 2024 | Defencath |
| Merck Sharp & Dohme LLC | $16.51 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muna Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.